Vitreomacular traction and exudative age-related macular degeneration

Acta Ophthalmologica

Volumn 86, Issue 5, 2008, Pages 470-481

  Schulze, Stephan ^a   Hoerle, Steffen ^a   Mennel, Stefan ^a   Kroll, Peter ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Age related macular degeneration; Ischaemia; Posterior vitreous detachment VEGF; Vitreomacular traction

Indexed keywords

DISEASE ASSOCIATION; HUMAN; HYPOXIA; INFLAMMATION; MOLECULAR GENETICS; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; REVIEW; SUBRETINAL NEOVASCULARIZATION; VITRECTOMY; VITREOMACULAR TRACTION; VITREOUS BODY DETACHMENT; VITREOUS DISEASE;

ADHESIVENESS; EXUDATES AND TRANSUDATES; HUMANS; MACULAR DEGENERATION; RETINA; TISSUE ADHESIONS; VITREOUS BODY;

EID: 48449101315     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01210.x     Document Type: Review

References (109)

1. Aiello LP, Northrup JM, Keyt BA, Takagi H & Iwamoto MA (1995): Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 113: 1538-1544.
2. Allikmets R, Shroyer N, Singh N et al. (1997): Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277: 1805-1807.
3. Bailey TA, Kanuga N, Romero IA, Greenwood J, Luthert PJ & Cheetham ME (2004): Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 45: 675-684.
4. Beatty S, Koh H, Phil M, Henson D & Boulton M (2000): The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45: 115-134.
5. Bird AC & Marshall J (1986): Retinal pigment epithelial detachments in the elderly. Trans Ophthalmol Soc U K 105: 674-682.
6. Boulton M, McKechnie NM, Breda J, Bayly M & Marshall J (1989): The formation of autofluorescent granules in cultured human RPE. Invest Ophthalmol Vis Sci 30: 82-89.
7. Capeans C, Lorenzo J, Santos L, Suarez A, Copena MJ, Blanco MJ & Sanchez-Salorio M (1998): Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 236: 481-485.
8. Chan CK, Wessels IF & Friedrichsen EJ (1995): Treatment of idiopathic macular holes by induced posterior vitreous detachment. Ophthalmology 102: 757-767.
9. Charbonnel J, Glacet-Bernard A, Korobelnik J, Nyouma-Moune E, Pournaras CJ, Colin J, Coscas G & Soubrane G (2004): Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol 242: 223-228.
10. Choe M, Jackson C & Yu BP (1995): Lipid peroxidation contributes to age-related membrane rigidity. Free Radic Biol Med 18: 977-984.
11. Chu T, Lopez PF, Cano MR, Freeman WR, Lean JS, Liggett PE, Thomas EL & Green RL (1996): Posterior vitreoschisis - an echographic finding in proliferative diabetic retinopathy. Ophthalmology 103: 315-322.
12. Chuang EL & Bird AC (1988): Repair after tears of the retinal pigment epithelium. Eye 2: 106-113.
13. Chuo JY, Lee TYY, Hollands H, Morris AH, Reyes RC, Rossiter JD, Meredith SP & Maberley DAL (2006): Risk factors for posterior vitreous detachment: A case-control study. Am J Ophthalmol 142: 931-937.
14. Doi N, Uemura A, Nakao K & Sakamoto T (2005): Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy. Retina 25: 742-745.
15. Donoso LA, Kim D, Frost A, Callahan A & Hageman G (2006): The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 51: 137-152.
16. Eagle RJ (1984): Mechanisms of maculopathy. Ophthalmology 91: 613-625.
17. Edwards AO, Ritter III R, Abel KJ, Manning A, Panhuysen C & Farrer LA (2005): Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
18. Eldred GE & Lasky MR (1993): Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature 361: 724-726.
19. Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, Egan K & Gragoudas ES (1995): Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 102: 640-646.
20. Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S & Hori S (2003a): Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular oedema. Ophthalmology 110: 1690-1696.
21. Funatsu H, Yamashita H, Ikeda T, Mimura T, Shimizu E & Hori S (2003b): Relation of diabetic macular oedema to cytokines and posterior vitreous detachment. Am J Ophthalmol 135: 321-327.
22. Gaillard ER, Atherton SJ, Eldred G & Dillon J (1995): Photophysical studies on human retinal lipofuscin. Photochem Photobiol 61: 448-453.
23. Gao H & Hollyfield JG (1992): Ageing of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 33: 1-17.
24. Gass JD (1967): Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 63(Suppl.):1-139.
25. Gass JD (1984a): Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol 68: 513-519.
26. Gass JD (1984b): Serous retinal pigment epithelial detachment with a notch. A sign of occult choroidal neovascularization. Retina 4: 205-220.
27. Gass JDM (1988): Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 106: 629-639.
28. Green SN & Yarian D (1983): Acute tear of the retinal pigment epithelium. Retina 3: 16-20.
29. Green WR, McDonnell PJ & Yeo JH (1985): Pathologic features of senile macular degeneration. Ophthalmology 92: 615-627.
30. 8 injection. Aust N Z J Ophthalmol 26: 311-317.
31. Gulkilik G, Kocabora S, Taskapili M & Engin G (2006): Cystoid macular oedema after phacoemulsification: Risk factors and effect on visual acuity. Can J Ophthalmol 41: 699-703.
32. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH & Mullins RF (2001): An integrated hypothesis that considers drusen as immune-mediated processes at the RPE-Bruch's membrane interface in ageing and age-related macular degeneration. Prog Ret Eye Res 20: 705-732.
33. Harris A, Chung HS, Ciulla TA & Kagemann L (1999): Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res 18: 669-687.
34. Hayreh SS & Jonas JB C2004): Posterior vitreous detachment: clinical correlations. Ophthalmologica 18: 333-343.
35. Hesse L, Nebeling B, Schroeder B, Heller G & Kroll P (2000): Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res 70: 31-39.
36. Hikichi T, Konno S & Trempe CL (1995): Role of the vitreous in central retinal vein occlusion. Retina 15: 29-33.
37. Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M & Yoshida A (1997): Association between the short-term natural history of diabetic macular oedema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104: 473-478.
38. Hoerle S, Poestgens H, Schmidt J & Kroll P (2002): Effect of pars plana vitrectomy for proliferative diabetic vitreoretinopathy on pre-existing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 240: 197-201.
39. Hollyfield JG, Varner HH, Rayborn ME & Osterfeld AM (1989): Retinal attachment to the pigment epithelium: Linkage through an extracellular sheath surrounding cone photoreceptors. Retina 9: 59-68.
40. Holz FG, Pauleikhoff D, Klein R & Bird AC (2004): Pathogenesis of lesions in age-related macular disease. Am J Ophthalmol 137: 504-510.
41. Johnson MW (2005): Perifoveal vitreous detachment and its macular complications. Trans Am Ophthalmol Soc 103: 537-567.
42. Johnson TM, Vaughn CW & Glaser BM (2006): Branch retinal vein occlusion associated with vitreoretinal traction. Can J Ophthalmol 41: 600-602.
43. Jorge R, Costa RA, Cardillo JA, Uno F, Bonomo PP & Farah ME (2006): Optical coherence tomography evaluation of idiopathic macular hole treatment by gas-assisted posterior vitreous detachment. Am J Ophthalmol 142: 869-871.
44. Kakehashi A, Schepens CL, de Sousa-Neto A, Jalkh AE & Trempe CL (1993): Biomicroscopic findings of posterior vitreoschisis. Ophthalmic Surg 24: 846-850.
45. Kakehashi A, Kado M, Akiba J & Hirokawa H (1997): Variations of posterior vitreous detachment. Br J Ophthalmol 81: 527-532.
46. Kishi S, Hagimura N & Shimizu K (1996): The role of the premacular liquefied pocket and premacular vitreous cortex in idiopathic macular hole development. Am J Ophthalmol 122: 622-628.
47. Krebs I, Brannath W, Glittenberg C, Zeiler F, Sebag J & Binder S (2007): Posterior macuAar adhesion: a potential risk factor for exudative age-related macular degeneration? Am J Ophthalmol 144: 741-746.
48. Kroll P, Wiegand W & Schmidt J (1999): Vitreopapillary traction in proliferative diabetic vitreoretinopathy. Br J Ophthalmol 83: 261-264.
49. Lambert HM, Capone A, Aaberg TM, Sterberg P, Mandell BA & Lopez PF (1992): Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 113: 257-262.
50. Larsson L & Oesterlin S (1985): Posterior vitreous detachment - a combined clinical and physicochemical study. Graefes Arch Clin Exp Ophthalmol 223: 92-95.
51. Matsumura N, Ikuno Y & Tano Y (2004): Posterior vitreous detachment and macular hole formation in myopic foveoschisis. Am J Ophthalmol 138: 1071-1073.
52. Meyer CH (2007): Current treatment approaches in diabetic macular oedema. Ophthalmologica 221: 118-131.
53. Meyer CH & Toth CA (2001): Retinal pigment epithelial tear with vitreomacular attachment: A novel pathogenic feature. Graefes Arch Clin Exp Ophthalmol 239: 325-333.
54. Mirza RG, Johnson MW & Jampol LM (2007): Optical coherence tomography use in evaluation of the vitreoretinal interface: A review. Surv Ophthalmol 52: 397-421.
55. Modarres M, Sanjari MS & Falavarjani KG (2007): Vitrectomy and release of presumed epipapillary vitreous traction for treatment of non-arteritic anterior ischaemic optic neuropathy associated with partial posterior vitreous detachment. Ophthalmology 114: 340-344.
56. Moore DJ, Hussain AA & Marshall J (1995): Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci 36: 1290-1297.
57. Mousa SA, Lorelli W & Campochiaro PA (1999): Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. J Cell Biochem 74: 135-143.
58. Murakami T, Takagi H, Ohashi H et al. (2007): Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular oedema with central retinal vein occlusion. Retina 27: 1031-1037.
59. Murphy RP, Yeo JH, Green WR & Patz A (1985): Dehiscences of the pigment epithelium. Trans Am Ophthalmol Soc 83: 63-81.
60. Nasrallah FP, Jalkh AE, van Coppenolle F, Kado M, Trempe CL, McMeel JW & Schepens CL (1988): The role of the vitreous in diabetic macular oedema. Ophthalmology 95: 1335-1339.
61. Nussenblatt RB & Ferris III F (2007): Age-related macular degeneration and the immune response: Implications for therapy. Am J Ophthalmol 144: 618-626.
62. Ondes F, Yilmaz G, Acar MA, UnlüN, Kocaoglan H & Arsan AK (2000): Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol 44: 91-93.
63. Ozaki H, Hayashi H, Vinores SA, Moromizato Y, Campochiaro PA & Oshima K (1997): Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res 64: 505-517.
64. Patel N, Adewoyin T & Chong NV (2007): Age-related macular degeneration: A perspective on genetic studies. Eye Doi:.
65. Pauleikhoff D, Harper CA, Marshall J & Bird AC (1990): Ageing changes in Bruch's membrane: A histochemical and morphological study. Ophthalmology 97: 171-178.
66. Pauleikhoff D, Spital G, Radermacher M, Brumm GA, Lommatzsch A & Bird AC (1999): A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol 117: 1353-1358.
67. Penfold PL, Killingsworth MC & Sarks SH (1985): Senile macular degeneration. The involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 223: 69-76.
68. Perichon JY, Brasseur G & Uzzan J (1993): Etude échographique du décollement postérieur du vitréchez l'emmétrope [Ultrasonic study of posterior vitreous detachment in emmetropic eyes]. J Fr Ophtalmol 16: 538-544.
69. Quaranta-El Maftouhi M & Mauget-Faysse M (2006): Anomalous vitreoretinal adhesions in patients with exudative age-related macular degeneration: An OCT study. Eur J Ophthalmol 16: 134-137.
70. Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PGH & de Jong PTVM (1994): Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in ageing. Invest Ophthalmol Vis Sci 35: 2857-2864.
71. Reese AB, Jones IS & Cooper WC (1967): Macular changes secondary to vitreous traction. Am J Ophthalmol 64: 544-549.
72. Rizzo S, Pellegrini G, Benocci F, Belting C, Baicchi U & Vispi M (2006): Autologous plasmin for pharmacologic vitreolysis prepared 1hour before surgery. Retina 26: 792-796.
73. Roberts WG & Palade GE (1995): Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108: 2369-2379.
74. Rodrigues EB (2007): Inflammation in dry age-related macular degeneration. Ophthalmologica 221: 143-152.
75. Roldan M & Serrano JM (1989): Macular oedema and vitreous detachment. Ann Ophthalmol 21: 141-148.
76. Ryan SJ, Hinton DR & Murata T (2001): Choroidal neovascularization. In: Ryan SJ (ed.) Retina, 3rd edn. St. Louis, MO: Mosby 1005-1006.
77. Sahni J, Stanga P, Wong D & Harding S (2005): Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: A cross-sectional study. Br J Ophthalmol 89: 316-320.
78. Sarks JP, Sarks SH & Killingsworth MC (1994): Evolution of soft drusen in age-related macular degeneration. Eye 8: 269-283.
79. Schlingemann RO (2004): Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 242: 91-101.
80. Schmidt JC, Mennel S, Hoerle S & Meyer HC (2006): High incidence of vitreomacular traction in recurrent choroidal neovascularization after repeated photodynamic therapy. Br J Ophthalmol 90: 1361-1362.
81. Schmidt-Erfurth UM, Richard G, Augustin A et al. (2007): Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand 85: 486-494.
82. Scholl HPN, Fleckenstein M, Issa PC, Keilhauer C, Holz FG & Weber BHF (2007): An update on the genetics of age-related macular degeneration. Mol Vis 13: 196-205.
83. Schubert HD (1989)T Cystoid macular oedema: the apparent role of mechanical factors. Prog Clin Biol Res 312: 277-291.
84. Schumann RG, Schaumberger MM, Rohleder M, Haritoglou C, Kampik A & Gandorfer A (2006): Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: A consecutive analysis of 100 cases. Am J Ophthalmol 141: 1112-1119.
85. Sebag J (1987): Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 225: 89-93.
86. Sebag J (1998): Vitreous - from biochemistry to clinical relevance. In: Tasman W & Jaeger EA (eds). Duane's Foundations of Clinical Ophthalmology, Vol.1. Philadelphia: Lippincott Williams & Wilkins; Chapter 16.
87. Sebag J (2004): Anomalous posteriorAvitreous detachment: a unifying concept in vitreoretinal disease. Graefes Arch Clin Exp Ophthalmol 242: 690-698.
88. Sebag J & Balazs EA (1984): Pathogenesis of cystoid macular oedema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 29: 493-498.
89. Sebag J & Hageman GS (2000): Interfaces. Eur J Ophthalmol 10: 1-3.
90. Sebag J, Buckingham B, Charles MA & Reiser K (1992): Biochemical abnormalities of vitreous in humans with proliferative diabetic retinopathy. Arch Ophthalmology 110: 1472-1476.
91. Sebag J, Ansari RR & Suh KI (2007): Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefes Arch Clin Exp Ophthalmol 245: 576-580.
92. Seitsonen S, Järvelä I, Meri S, Tommila P, Ranta P & Immonen I (2008): Complement factor H Y402H polymorphism and characteristics of exudative age-related macular degeneration lesions. Acta Ophthalmol 86: 390-394.
93. Seko Y, Seko Y, Fujikura H, Pang J, Tokoro T & Shimakawa H (1999): Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro. Invest Ophthalmol Vis Sci 40: 3287-3291.
94. Smiddy WE, Maguire AM, Green WR, Michels RG, de la Cruz Z, Enger C, Jaeger M & Rice TA (1989): Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology 98: 811-821.
95. Spaide RF (2003): Measurement of the posterior precortical vitreous pocket in fellow eyes with posterior vitreous detachment and macular holes. Retina 23: 481-485.
96. Spaide RF, Armstrong D & Browne R (2003): Choroidal neovascularization in age-related macular degeneration - what is the cause? Retina 23: 595-614.
97. Stefansson E (1990): Oxygen and diabetic eye disease. Graefes Arch Clin Exp Ophthalmol 228: 120-123.
98. Stefansson E (2001): The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 79: 435-440.
99. Stefansson E & Loftsson T (2006): The Stokes-Einstein equation and the physiological effects of vitreous surgery. Acta Ophthalmol Scand 84: 718-719.
100. Terasaki H, Kojima T, Niwa H, Piao C, Ueno S, Kondo M, Ito Y & Miyake Y (2003): Changes in focal macular electroretinograms and foveal thickness after vitrectomy for diabetic macular oedema. Invest Ophthalmol Vis Sci 44: 4465-4472.
101. Theodossiadis PG, Grigoropoulos VG, Emfietzoglou J & Theodossiadis GP (2007): Vitreous findings in optic disc pit maculopathy based on optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 245: 1311-1318.
102. Uchino E, Uemura A & Ohba N (2001): Initial stage of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol 119: 1475-1479.
103. Virgili G, Do DV, Bressler NM & Menchini U (2007): New therapies for neovascular age-related macular degeneration: Critical appraisal of the current evidence. Acta Ophthalmol Scand 85: 6-20.
104. Weber-Krause B & Eckardt U (1996): Häufigkeit einer hinteren Glaskörperabhebung bei Augen mit und ohne altersabhängige Makuladegeneration [Incidence of posterior vitreous detachment in eyes with and without age-related macular degeneration. An ultrasonic study]. Ophthalmologe 93: 660-665.
105. Witmer AN, Vrensen GFJM, Van Noorden CJF & Schlingemann RO (2003): Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22: 1-29.
106. Yamagishi K, Okhuma H, Itagaki T, Katoh N, Takahashi K & Uyama M (1988): Implication of retinal pigment epithelium on experimental subretinal neovascularization in the developmental stage. Nippon Ganka Gakkai Zasshi 92: 1629-1636.
107. Yamamoto S, Yamamoto T, Ogata K, Hoshino A, Sato E & Mizunoya S (2004): Morphological and functional changes of the macula after vitrectomy and creation of posterior vitreous detachment in eyes with diabetic macular oedema. Doc Ophthalmol 109: 249-253.
108. Zayit-Soudry S, Moroz I & Loewenstein A (2007): Retinal pigment epithelial detachment. Surv Ophthalmol 52: 227-243.
109. Zhang SX & Ma J (I007): Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 26: 1-37.